共 198 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2018)Current status of neoadjuvant endocrine therapy in early stage breast Cancer Curr Treat Options in Oncol 19 23-395
[3]
Soerjomataram I(1987)Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base Am J Clin Oncol 10 387-827
[4]
Siegel RL(2009)Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk Ann Oncol 20 816-1988
[5]
Torre LA(2015)Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy Circulation 131 1981-42
[6]
Jemal A(2020)Cardiotoxicity of anthracyclines Front Cardiovasc Med 7 26-361
[7]
Reinert T(2016)Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging Circ Heart Fail 9 e002661-449
[8]
Gonçalves R(2017)2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) Eur J Heart Fail 19 9-274
[9]
Ellis MJ(2016)Curing cancer, saving the heart: a challenge that cardioncology should not miss Curr Cardiol Rep 18 51-1788
[10]
Jones SE(1995)Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients Med Pediatr Oncol 24 352-2223